Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Institut National de Recherche en Informatique et en Automatique | OTHER |
Not provided
Not provided
Not provided
Not provided
Parkinson's disease (PD) is the second most common neurodegenerative disease. Multiple system atrophy (MSA) is a relentlessly progressing rare neurodegenerative disease of unknown etiology. In early stages of the disease, PD and MSA symptoms are very similar, particularly MSA-P where Parkinsonism predominates. The differential diagnosis between MSA-P and PD can be very challenging in early disease stages, while early diagnostic certitude is important for the patient because of the diverging prognosis. Voice disorders are a common early symptom in both diseases and of different origin. The ambition and the originality of this project are to develop a digital voice-based tool for objective discrimination between PD and MSA-P.
Given the clinical similarity between PD and MSA-P in early disease stages and the severity of the prognosis of MSA-P, it would be very useful to have objective tools to assist in the differential diagnosis between both disorders. Since dysarthria is a common early symptom in both diseases and of different origin, the innovative goal of this project is to use dysarthria, through a digital processing of voice recordings of patients, as a vehicle to distinguish between PD and MSA-P in early disease stages.
The team will build a corpus of voice samples of patients with both diseases and a recent diagnosis (less than 4 years) and controls. This corpus will consist in sustained vowels, utterances of a standard text and spontaneous speech. The recordings will be performed using a high quality digital recorder (H4n) and the DIANA and EVA-2 workstations. DIANA is a state-of-the-art system dedicated to pathological voice recording and analysis.
An electroglottograph (EGG), a non-invasive device, will be also used in conjunction with the recordings to provide the ground truth of glottal opening and closure instants during utterances. The use of an EGG can be very useful given that OGI and GCI provide valuable information about the voice short-time dynamics.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Parkinson's disease | Other | Diagnosis of idiopathic Parkinson's disease (PD) according to criteria |
|
| Multiple system atrophy | Other | Diagnosis of Multiple Atrophy System (MSA) Parkinsonian form possible or probable according to Gilman et coll 's criteria (2008) |
|
| Healthy volunteer | Other | Absence of neurologic and oto-rhino-laryngologic disease |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| voice recordings | Procedure | A digital processing of voice recordings (from 30 to 45 minutes) will be performed for each participant, using a high quality digital recorder: the DIANA (computerized device of acoustic analysis) and the EVA-2 workstations (assisted Evaluation system Voice). |
| Measure | Description | Time Frame |
|---|---|---|
| Differences between groups in Dysphonia Severity Index (DSI). | DSI will be calculated with the SESANE software (http://www.sqlab.fr/) and with algorithms developed by GeoStat at Inria. Evaluation of the rhythm voice
Aerodynamic voice parameters will be assessed with the DIANA system (http://www.sqlab.fr/) and algorithms specifically developed by GeoStat at Inria. | Day 1 |
| Differences between groups in Acoustic Voice Quality Index (AVQI) | AVQI will be calculated with the SESANE software (http://www.sqlab.fr/) and with algorithms developed by GeoStat at Inria. Objective measurement of overall voice quality consisted of determining the acoustic parameters for calculating AVQI: smoothed cepstral peak prominence (CPPs) with the computer program "SpeechTool" (James Hillenbrand, Western Michigan University, Kalamazoo, MI, USA) and harmonics-to-noise ratio (HNR), shimmer local, shimmer local dB, general slope of the spectrum (slope) and tilt of the regression line through the spectrum (tilt) with Praat. Te Acoustic Voice Quality Index (AVQI) was calculated according to the regression formula: 2.571 [3.295 - 0.111 (CPPs) - 0.073 (HNR) - 0.213 (shimmer local) + 2.789 (shimmer local dB) - 0.032 (slope) + 0.077 (tilt)]. | Day 1 |
| Differences between groups in oral airflow (dm3/s). | This parameter will be evaluated with the EVA2 system (http://www.sqlab.fr/). | Day 1 |
| Differences between groups in glottal leakage (cc/s/dB) |
| Measure | Description | Time Frame |
|---|---|---|
| Differences between groups in perceptive analysis of dysphonia based on total GRBAS-I scale scores (range 0-18) | The GRBAS-I scale evaluates six items, i.e. G (Grade), R (Roughness), B (Breathiness), A (Asthenicity), S (Strained) and I (Instability) | Day 1 |
| Differences between groups in perceptive analysis of dysarthria based on French Clinical Dysarthria Battery scores |
Not provided
Inclusion Criteria:
Patient with Parkinson's disease :
Patients with MSA-P (Parkinsonian form) :
Controls :
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Wassilios MEISSNER, MD,PhD | University Hospital, Bordeaux | Principal Investigator |
| Khalid DAOUDI, PhD | Institut National de Recherche en Informatique et en Automatique | Study Chair |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Centre Hospitalier Universitaire de Bordeaux | Bordeaux | 33000 | France | |||
| Centre Hospitalier Universitaire de Toulouse |
Not provided
| ID | Term |
|---|---|
| D010300 | Parkinson Disease |
| D012791 | Shy-Drager Syndrome |
| ID | Term |
|---|---|
| D020734 | Parkinsonian Disorders |
| D001480 | Basal Ganglia Diseases |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
Not provided
Not provided
Exploratory comparative multicentric study.
Not provided
Not provided
Not provided
Not provided
|
This parameter will be evaluated with the EVA2 system (http://www.sqlab.fr/). |
| Day 1 |
| Differences between groups in intra-oral pressure (hPa). | This parameter will be evaluated with the EVA2 system (http://www.sqlab.fr/). | Day 1 |
Sum of all 12 prosody item scores and all 6 phonetic performance item scores; range 0-84. |
| Day 1 |
| Toulouse |
| 31000 |
| France |
| D009422 | Nervous System Diseases |
| D009069 | Movement Disorders |
| D000080874 | Synucleinopathies |
| D019636 | Neurodegenerative Diseases |
| D019578 | Multiple System Atrophy |
| D054969 | Primary Dysautonomias |
| D001342 | Autonomic Nervous System Diseases |
| D007022 | Hypotension |
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |